In our next Case Conversation program on Tuesday, May 24th, from 12:00-1:00 p.m. ET (11:00 a.m. - 12:00 p.m. CT, 10:00 - 11:00 a.m. MT, 9:00-10:00 a.m. PT), where Dr. Michele Lambert…
The Foundation for Women & Girls with Blood Disorders Research Awards provide financial support for qualified fellows or junior attending/junior faculty pursuing clinical, t…
Dr. Leslie Appiah of the University of Colorado will be presenting at NASPAG's upcoming Fertility Preservation: Optimizing Outcomes webinar on January 13 from 8-9 pm ET.
Congratulations to Dr. Roshni Kulkarni, Winner of the Coalition for Hemophilia B's 2022 Eternal Spirit Award
Our congratulations to Dr. Roshni Kulkarni, FWGBD Co-Founder and Board Member, for her selection as the 2022 Coalition for Hemophilia B's Eternal Spirit Award.
MAC Member Dr. Michael Paidas has co-developed a novel therapeutic that acts as a "net" to prevent COVID-19 from entering cells.
Dr. Andrew is researching clinical trial design for postpartum women with risk of venous thromboembolism (VTE).
NASPAG has created a set of talking points to help health care providers answer questions from parents and adolescents about the safety and efficacy of the Pfizer-BioNtech vaccine.
The CDC has recently released updated statistics about hemophilia characteristics among women and girls receiving care at specialized Hemophilia Treatment Centers (HTCs) in the United States.